ALK-Abelló A/S (OTCMKTS:AKBLF – Get Free Report)’s share price was down 6.7% on Thursday . The stock traded as low as $37.9150 and last traded at $37.9150. Approximately 100 shares were traded during mid-day trading, a decline of 81% from the average session volume of 525 shares. The stock had previously closed at $40.65.
ALK-Abelló A/S Trading Down 6.7%
The company’s 50-day moving average price is $38.58 and its 200-day moving average price is $35.89.
ALK-Abelló A/S Company Profile
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Featured Stories
- Five stocks we like better than ALK-Abelló A/S
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
